InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
1
T+90 胜率
100%
T+90 平均收益
+9.6%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Pizzie Nick, 首席财务官. Director active across 1 company, notably Axsome Therapeutics, Inc.. Cumulatively, 5 disclosures have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €17k. History available since 18 November 2021. The latest transaction was disclosed on 22 January 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Pizzie Nick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
33,000 股Common StockSEC:0001193125-26-264035:0
33,000 股Common StockSEC:0001193125-26-264035:1
12,000 股@ US$3.5038.7% 占其流量Common StockSEC:0001193125-26-021378:0
12,000 股@ US$3.5055.0% 占其流量Common StockSEC:0000950170-25-021716:0
527 股@ US$35.500.2% 占其流量Common StockSEC:0001209191-21-066005:0
标准退出：2022年2月16日 (T+90)
5 条申报中的 5 条
About Pizzie Nick
Nick Pizzie is the Chief Financial Officer of Axsome Therapeutics, Inc. He is responsible for the financial management of the company, overseeing financial operations and strategic planning. Nick plays a key role in optimizing financial performance and achieving Axsome's growth objectives.
